ArticleBlood advances2022

Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo.

Xiaoshan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.